REVUE DE PRESSE
Réf. :HematoStat.net ; 2 (12) : R62 Laetsch TW, Maude SL, Rives S, Hiramatsu H, Bittencourt H, Bader P, et al. Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult […]
Réf. :HematoStat.net ; 2 (12) : R61 Ventricular arrhythmias and sudden death events following acalabrutinib initiation. Bhat SA, Gambril J, Azali L, Chen ST, Rosen L, Palettas M, et al. […]
Réf. :HematoStat.net ; 2 (12) : R60 Teclistamab in Relapsed or Refractory Multiple Myeloma. N Engl J Med. Moreau P, Garfall AL, van de Donk NWCJ, Nahi H, San-Miguel JF, Oriol […]
Réf. :HematoStat.net ; 2 (12) : R59 Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine. Döhner H, Wei AH, Roboz […]